Clinical Trial Update: Treatment for Endogenous Cushing's Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for a treatment of endogenous Cushing's syndrome has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endogenous Cushing Syndrome

Snippet

Sponsor: Cortendo AB | Conditions: Endogenous Cushing's Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2021-04-19